Targeting chemotherapy with genetic testing provides effective treatment for women with aggressive breast cancer

Women with an aggressive form of breast cancer who have faults in their BRCA genes do much better on chemotherapy drug carboplatin than standard treatment, a major clinical trial reports.
Institute of Cancer Research